Update of INR-selfmonitoring;Neue Aspekte des INR-Selbstmonitorings

Hamostaseologie

Volumn 28, Issue 4 A/SUPPL. 1, 2008, Pages 231-233

  Voller H ^a   Braun, S ^b  

^a Abteilung für Kardiologie   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

INR selfmonitoring; Oral anticoagulation; Vitamin K antagonists

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ARTICLE; BLOOD CLOTTING; HUMAN; INTERNATIONAL NORMALIZED RATIO; METHODOLOGY; MIDDLE AGED; MONITORING; PHYSIOLOGY; REPRODUCIBILITY; SELF CARE; TELEMEDICINE;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; MONITORING, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS; SELF CARE; TELEMEDICINE;

EID: 56149114091     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617106     Document Type: Article

References (27)

1. Hohnloser S, Chrolavicius S, Pfeffer M et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367: 1903-1912.
2. Ansell J, Jacobson A, Levy J et al International Self-Monitoring Association for Oral Anticoagulation. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-MonitoringAs-sociation for Oral Anticoagulation. Int J Cardiol 2005; 9: 37-45.
3. Ansell JE, Patel N, Ostrovsky D et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995; 155: 2185-2189.
4. Bauman ME, Black KL, Massicotte MP et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103.
5. Bereznicki LR, Jackson SL, Peterson GM et al. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007; 60: 311-314.
6. Bernardo A, Völler H, Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation A. Guidelines for "coagulation self-management". Deutsche Med Wochenschr 2001; 126: 346-351.
7. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: a randomized, controlled trial. Ann Intern Med 2000; 133: 687-695.
8. Braun S, Watzke H, Hasenkam JM et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314.
9. Braun SL, Soppa C, Taborski U et al. Qualitätssicherung der Patientenschulung zur Selbstkontrolle der Antikoagulation. Z ärztl Fortbild Qual Gesundhwes 2007; 101: 194-195.
10. Christensen TD, Johnsen SP, Hjortdal VE et al. Self-management of oral anticoagulant therapy: A systematic review and meta-analysis. Int J Cardiol 2007; 118: 54-61.
11. Dorfman DM, Goonan EM, Boutilier MK et al. Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med 2005; 10: 23-27.
12. Hasenkam JM, Kimose HH, Knudsen L et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997; 11: 935-942.
13. Heneghan C, Alonso-Coello P, Garcia-Alamino JM et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411.
14. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998; 5: 19-24.
15. Körtke H, Zittermann A, Tenderich G et al. Lowdose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J 2007; 28: 2479-2484.
16. Menendez-Jandula B, Souto JC, Oliver A et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med 2005; 142: 1-10.
17. Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek(TM) S point-of-care monitor and a robust education program. Thrombs Res 2006; 118: 587-593.
18. Sidhu P, O'Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 2001; 72: 1523-1527.
19. Siebenhofer A, Rakovac I, Kleespies C et al. Selfmanagement of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year of follow-up. Thromb Haemost 2007; 97: 408-416.
20. ® S and an established laboratory method. J Thromb Thrombolysis 2004; 18: 103-107.
21. Testa S, Alatri A, Paoletti O et al. Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results. Intern Emerg Med 2006; 1: 24-29.
22. Van den Besselaar AM, Breddin K, Lutze G et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis 1995; 6: 726-732.
23. Van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001; 12: 35-40.
24. Völler H, Dovifat C, Glatz J et al. Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures. Eur J Cardiovasc Prev Rehabil 2004; 11: 442-447.
25. Völler H, Dovifat C, Wegscheider K. Experience with INR self-management: patient selection and complication rates. Z Kardiol 2005; 94: 801-807.
26. Völler H, Taborski U, Dovifat C et al. ProTime self-management yielding improvement of fluency and quality of life. Thromb Haemost 2007; 98: 889-895.
27. White RH, McCurdy SA, von Marensdorff H et al. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 1989; 111: 730-737.